LRRK2 and Parkinson disease: Nonetheless, increased levels of LRRK2 appear to be directly related to the pathogenicity/toxicity of PD-related mutations, at least for the LRRK2G2019S mutation [34], which is one of the mutations most frequently associated with PD.